198 related articles for article (PubMed ID: 10760204)
1. Transfusion of platelet concentrates from pooled buffy-coats: comparison of bedside vs. prestorage leukofiltration.
Müller-Steinhardt M; Schlenke P; Wagner T; Klüter H
Transfus Med; 2000 Mar; 10(1):59-65. PubMed ID: 10760204
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of transfusion of prestorage-leukoreduced apheresis platelets.
Ogawa Y; Wakana M; Tanaka K; Oka K; Aso H; Hayashi M; Seno T; Ishida T; Nomura S; Fukuhara S
Vox Sang; 1998; 75(2):103-9. PubMed ID: 9784662
[TBL] [Abstract][Full Text] [Related]
3. In-vivo evaluation of random donor platelet concentrates from pooled buffy coats.
Klüter H; Dörges L; Maass E; Wagner T; Bartels H; Kirchner H
Ann Hematol; 1996 Aug; 73(2):85-9. PubMed ID: 8774617
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of platelet function using the in vitro bleeding time and corrected count increment of transfused platelets. Comparison between platelet concentrates derived from pooled buffy coates and apheresis.
Eriksson L; Kristensen J; Olsson K; Bring J; Högman CF
Vox Sang; 1996; 70(2):69-75. PubMed ID: 8801766
[TBL] [Abstract][Full Text] [Related]
5. Benefit of prestorage leukocyte depletion of single-donor platelet concentrates.
Chalandon Y; Mermillod B; Beris P; Doucet A; Chapuis B; Roux-Lombard P; Dayer JM
Vox Sang; 1999; 76(1):27-37. PubMed ID: 9933851
[TBL] [Abstract][Full Text] [Related]
6. Transfusion of platelet concentrates--clinical evaluation of two preparations.
Strindberg J; Berlin G
Eur J Haematol; 1996 Oct; 57(4):307-11. PubMed ID: 8982294
[TBL] [Abstract][Full Text] [Related]
7. Effect of prestorage leukocyte removal on the cytokine levels in stored platelet concentrates.
Muylle L; Peetermans ME
Vox Sang; 1994; 66(1):14-7. PubMed ID: 8146977
[TBL] [Abstract][Full Text] [Related]
8. A prospective randomized study of three types of platelet concentrates in patients with haematological malignancy: corrected platelet count increments and frequency of nonhaemolytic febrile transfusion reactions.
Anderson NA; Gray S; Copplestone JA; Chan DC; Hamon M; Prentice AG; Johnson SA; Phillips M; van Waeg G; Oakhill A; Abeyasekera S; Pamphilon DH
Transfus Med; 1997 Mar; 7(1):33-9. PubMed ID: 9089983
[TBL] [Abstract][Full Text] [Related]
9. The flow rate significantly influences the leukocyte depletion rate during prestorage in-line filtration of platelet concentrates.
Janetzko K; Schlenke P; Klüter H
Transfus Sci; 1999 Oct; 21(2):123-8. PubMed ID: 10747520
[TBL] [Abstract][Full Text] [Related]
10. A comparison of prestorage WBC-reduced whole-blood-derived platelets and bedside-filtered whole-blood-derived platelets in autologous progenitor cell transplant.
Sweeney JD; Kouttab NM; Penn CL; McHugh KE; Nelson EJ; Oblon DJ
Transfusion; 2000 Jul; 40(7):794-800. PubMed ID: 10924606
[TBL] [Abstract][Full Text] [Related]
11. Determination
Thuku NW; Shikuku K; Mbugua A
Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
[TBL] [Abstract][Full Text] [Related]
12. Preparation of leucocyte-poor platelet concentrates from buffy coats. IV. Clinical evaluation.
Pietersz RN; Reesink HW; Huijgens PC; van Oers MH
Vox Sang; 1988; 55(3):129-32. PubMed ID: 3070936
[TBL] [Abstract][Full Text] [Related]
13. Prestorage versus bedside white blood cell filtration of red blood cell concentrates: effects on the content of cytokines and soluble tumor necrosis factor receptors.
Kristiansson M; Soop M; Shanwell A; Sundqvist KG
J Trauma; 1996 Mar; 40(3):379-83. PubMed ID: 8601853
[TBL] [Abstract][Full Text] [Related]
14. Preparation of leukodepleted platelet concentrates from pooled buffy coats: prestorage filtration with Autostop BC.
Pietersz RN; van der Meer PF; Steneker I; Hinloopen B; Dekker WJ; van Zanten AP; Reesink HW
Vox Sang; 1999; 76(4):231-6. PubMed ID: 10394143
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of pooled platelet concentrates using prestorage versus poststorage WBC reduction: impact of filtration timing.
Ferrer F; Rivera J; Corral J; Gonzalez-Conejero R; Lozano ML; Vicente V
Transfusion; 2000 Jul; 40(7):781-8. PubMed ID: 10924604
[TBL] [Abstract][Full Text] [Related]
16. Febrile and allergic transfusion reactions after the transfusion of white cell-poor platelet preparations.
Klüter H; Bubel S; Kirchner H; Wilhelm D
Transfusion; 1999; 39(11-12):1179-84. PubMed ID: 10604243
[TBL] [Abstract][Full Text] [Related]
17. Leukocyte depletion and storage of single-donor platelet concentrates.
Weisbach V; Putzo A; Zingsem J; Riewald M; Zimmermann R; Eckstein R; Riess H
Vox Sang; 1997; 72(1):20-5. PubMed ID: 9031496
[TBL] [Abstract][Full Text] [Related]
18. Implementation of a new platelet pooling system for platelet concentrates led to a higher corrected count increment after transfusion: a comparative observational study of platelet concentrates before and after implementation.
Dijkstra-Tiekstra MJ; van de Watering LM; Rondeel JM; Slomp J; de Wildt-Eggen J
Transfus Med; 2014 Apr; 24(2):99-104. PubMed ID: 24506143
[TBL] [Abstract][Full Text] [Related]
19. Clinical effect of buffy-coat vs. apheresis platelet concentrates in patients with severe thrombocytopenia after intensive chemotherapy.
Akkök CA; Brinch L; Lauritzsen GF; Solheim BG; Kjeldsen-Kragh J
Vox Sang; 2007 Jul; 93(1):42-8. PubMed ID: 17547564
[TBL] [Abstract][Full Text] [Related]
20. Universal leukodepletion of blood components results in a significant reduction of febrile non-hemolytic but not allergic transfusion reactions.
Pruss A; Kalus U; Radtke H; Koscielny J; Baumann-Baretti B; Balzer D; Dörner T; Salama A; Kiesewetter H
Transfus Apher Sci; 2004 Feb; 30(1):41-6. PubMed ID: 14746820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
